scispace - formally typeset
S

S. Defranchi

Researcher at Fundación Favaloro

Publications -  5
Citations -  3009

S. Defranchi is an academic researcher from Fundación Favaloro. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 2, co-authored 2 publications receiving 1967 citations.

Papers
More filters
Journal ArticleDOI

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Peter Goldstraw, +142 more
TL;DR: The methods used to evaluate the resultant Stage groupings and the proposals put forward for the 8th edition of the TNM Classification for lung cancer due to be published late 2016 are described.
Journal ArticleDOI

The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer

Frank C. Detterbeck, +164 more
TL;DR: An extensive analysis has produced stage classification proposals for lung cancer with a robust degree of discriminatory consistency and general applicability and external validation is encouraged to identify areas of strength and weakness.
Journal ArticleDOI

S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) inhibits lung cancer tumorigenesis by regulating cell plasticity

TL;DR: In this paper , the expression of S-adenosylhomocysteine hydrolase-like protein 1 (AHCYL1) was analyzed in non-small cell lung cancer (NSCLC) cells from RNA-seq public data and surgical specimens, which revealed that AHCyl1 expression is downregulated in tumors and inverse correlated to proliferation marker Ki67 and the stemness signature expression.
Journal ArticleDOI

Argentine consensus recommendations for lung cancer screening programmes: a RAND/UCLA-modified Delphi study

TL;DR: A consensus of experts in Argentina was carried out to review the literature and generate recommendations for lung cancer screening programs as discussed by the authors , and a mixed-method study was used with three phases: (1) a review of the literature; (2) modified Delphi consensus panel; and (3) development of the recommendations.